AI risk alerts, new biomarkers and expanded screening are landing on primary care physicians without added time or staff. Shifting outreach, testing coordination and closed-loop referrals to partners can help practices close the gap.
|Articles|November 30, 2022
Coronavirus Omicron variant, vaccine, and case numbers in the United States: Nov. 30, 2022
Author(s)Logan Lutton
How many novel coronavirus (COVID-19) cases were announced today?
Advertisement
The
Here’s the latest data, updated on Nov. 30:
Positive tests: 98,673,988
Patient deaths: 1,079,870
Total vaccine doses distributed: 918,653,695
Patients who’ve received the first dose: 267,804,921
Patients who’ve received the second dose: 228,390,445
% of population fully vaccinated (both doses, not including boosters): 68.8%
% of population with an updated (bivalent) booster dose: 12.1%
% tied to Omicron variant: 99.9%
% tied to Other: 0.1%
Advertisement
Related to this article
Only 22 of the articles in a Georgetown scoping review defined health equity, a gap the lead author said could steer resources toward the most advantaged groups.
Key findings from the AMGA 2026 Medical Clinic Staffing Survey
Learn what a work RVU is, how Medicare's 2027 conversion factor turns RVUs into payment and how employers use wRVUs to set physician compensation.
Is the time coming for primary care to move beyond traditional insurance? It’s worth a conversation, said a leader of the American Academy of Family Physicians.
Higher Part D deductibles, rising Medigap and Part B premiums and the end of $0-premium drug plans may lead patients to skip refills and visits early in 2027. Here’s who is most exposed, why lower utilization could mask 2028 costs and what to do before Dec. 7 and in January.
The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.
In a controlled test of 12 AI models across 33 physician-written clinical cases, a clearly labeled pharmaceutical ad raised the share of responses choosing the advertised drug from 35% to 47.6%.
Advertisement
Advertisement
Trending on Medical Economics
1
Primary care Rx: Six ways to fix it, from the National Academy of Medicine
2
AI chatbot treatment recommendations are swayed by drug ads
3
How 2027 Medicare cost increases could lead patients to defer care — and what practices should do
4
Why Medicare’s 20% modifier 25 cut still penalizes same-day care
5